SEC Form 4 · accession 0001209191-17-059861
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shamim Ruff
Officer — SVP, Regulatory Affairs & Qual
Period of report
Nov 6, 2017
Accepted (ET)
Nov 8, 2017 · 8:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 6, 2017 | M | 10,000 | $14.76 | A | 37,045 | D | |
| Common StockF1 | Nov 6, 2017 | S | 10,000 | $55.00 | D | 27,045 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to buy)F1 | $14.76 | Nov 6, 2017 | M | 10,000 | D | May 6, 2016 | May 6, 2025 | Common Stock | 10,000 | 31,144 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.